CanSino’s INHALED vaccine gets emergency use approval in China

‘HONG KONG: China’s CanSino Biologics Inc said on Sunday (Sep 4) that its recently developed COVID-19 vaccine has been approved by the country’s drug regulator for emergency use as a booster, potentially benefiting its business.

The inhaled version of CanSino’s adenovirus-vectored COVID-19 vaccine has obtained the green light from the National Medical Products Administration, the company said in a filing on Sunday.

We are primarily funded by readers. Please subscribe and donate to support us!

“The approval will have a positive impact on the company’s performance if the vaccine is subsequently purchased and used by relevant government agencies,” CanSino said.’


Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.